<SEC-DOCUMENT>0001193125-15-261269.txt : 20150723
<SEC-HEADER>0001193125-15-261269.hdr.sgml : 20150723
<ACCEPTANCE-DATETIME>20150723165414
ACCESSION NUMBER:		0001193125-15-261269
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20150723
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150723
DATE AS OF CHANGE:		20150723

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UNITEDHEALTH GROUP INC
		CENTRAL INDEX KEY:			0000731766
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				411321939
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10864
		FILM NUMBER:		151002769

	BUSINESS ADDRESS:	
		STREET 1:		UNITEDHEALTH GROUP CENTER
		STREET 2:		9900 BREN ROAD EAST
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55343
		BUSINESS PHONE:		9529361300

	MAIL ADDRESS:	
		STREET 1:		9900 BREN ROAD EAST
		CITY:			MINNETONKA
		STATE:			MN
		ZIP:			55343

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP/
		DATE OF NAME CHANGE:	20000309

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d84129d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Current Report </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of The Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of report (Date of earliest event reported): July&nbsp;23, 2015 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>UNITEDHEALTH GROUP INCORPORATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>1-10864</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>41-1321939</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UnitedHealth Group Center, 9900 Bren Road East,</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Minnetonka, Minnesota</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>55343</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: (952)&nbsp;936-1300 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N/A</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or
former address, if changed since last report.) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;2.01.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Completion of Acquisition or Disposition of Assets. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;23, 2015, UnitedHealth
Group Incorporated (&#147;UnitedHealth Group&#148;) completed its indirect acquisition of Catamaran Corporation (&#147;Catamaran&#148;), pursuant to the previously announced arrangement agreement with 1031387 B.C. Unlimited Liability Company, its
wholly owned subsidiary, and Catamaran, and the statutory arrangement under the law of the Yukon Territory, Canada. As contemplated by the arrangement agreement, pursuant to the arrangement, all of the common shares of Catamaran issued and
outstanding immediately prior to the effective time of the arrangement were converted into the right to receive an amount in cash equal to $61.50 per share, without interest and less applicable withholding taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the arrangement agreement and the transactions contemplated thereby (including the arrangement) does not purport
to be complete and is subject to, and qualified in its entirety by, the full text of the arrangement agreement, a copy of which was attached as Exhibit 2.1 to UnitedHealth Group&#146;s Current Report on Form 8-K filed with the United States
Securities and Exchange Commission on March&nbsp;30, 2015, the terms of which are incorporated herein by reference. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;7.01.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Regulation FD Disclosure. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;23, 2015, Optum, a wholly owned subsidiary of
UnitedHealth Group, issued a press release announcing, among other things, the completion of Optum&#146;s combination with Catamaran, the scheduled redemption of Catamaran&#146;s outstanding public notes and the satisfaction and discharge of the
indenture relating thereto, and the payoff and termination of Catamaran&#146;s existing credit facility. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated in this Item&nbsp;7.01 by reference. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information set forth in this Item&nbsp;7.01 and Exhibit 99.1 shall not be deemed &#147;filed&#148; for purposes of Section&nbsp;18 of the
Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such
filing. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:23.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Description</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;2.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Arrangement Agreement, dated as of March 29, 2015, among UnitedHealth Group Incorporated, 1031387 B.C. Unlimited Liability Company and Catamaran Corporation (incorporated by reference to Exhibit 2.1 to UnitedHealth Group&#146;s
Current Report on Form 8-K filed on March 30, 2015)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release, dated July 23, 2015</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Signatures </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: July&nbsp;23, 2015 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">UNITEDHEALTH GROUP INCORPORATED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Richard J. Mattera</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Richard J. Mattera</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Assistant Secretary</TD></TR>
</TABLE></DIV>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:23.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Description</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;2.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Arrangement Agreement, dated as of March 29, 2015, among UnitedHealth Group Incorporated, 1031387 B.C. Unlimited Liability Company and Catamaran Corporation (incorporated by reference to Exhibit 2.1 to UnitedHealth Group&#146;s
Current Report on Form 8-K filed on March 30, 2015)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release, dated July 23, 2015</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d84129dex991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML><HEAD>
<TITLE>Exhibit 99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g84129img01.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>For Immediate Release </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OptumRx, Catamaran Complete Combination </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Combined company creates a new competitive force that will provide a connected, personalized pharmacy care experience for more than
65&nbsp;million Americans </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>OptumRx&#146;s scale and unique capabilities will help consumers and clients manage the cost and
treatment challenges of pharmaceuticals </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NEW YORK (July 23, 2015)</B> &#150; Optum announced the completion of its combination with Catamaran
Corporation [NASDAQ: CTRX, TSX: CCT]. Catamaran and Optum&#146;s pharmacy care services business, OptumRx, are expected to serve the needs of more than 65&nbsp;million people and fulfill more than one billion prescriptions in 2015. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The combination of Catamaran and OptumRx, which will operate as OptumRx, offers scaled, innovative pharmacy care services driving unmatched value to clients
and consumers. OptumRx&#146;s synchronized health care experience goes well beyond traditional pharmacy benefits management (PBM) by integrating Optum&#146;s data and analytics and connecting pharmacy care with a person&#146;s overall health
benefits and care management. This provides a complete care solution for consumers and promotes collaboration among pharmacists and care providers. The result is better health outcomes and cost savings as people consistently get the right
medications, care and guidance at the right time. As consumers, employers and payers increasingly need to access costly specialty pharmaceuticals, these synchronization capabilities set OptumRx apart in the marketplace. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are pleased to welcome the talented Catamaran team to OptumRx, and together we look forward to bringing uniquely powerful, combined pharmacy care
service offerings to the marketplace,&#148; said Larry Renfro, chief executive officer of Optum. &#147;OptumRx is now exceptionally well-positioned to support and connect pharmacists, care providers, payers and patients in achieving the shared goals
of improved health outcomes, better consumer experiences and lower costs.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;OptumRx now has the expertise, scale, resources and innovative
spirit to be the most valued, consumer-focused pharmacy care services partner in a rapidly changing health care system,&#148; said Mark Thierer, chief executive officer of OptumRx and former chairman and chief executive officer of Catamaran.
&#147;In addition to the consumer service enhancements and cost management opportunities this combination makes possible, OptumRx&#146;s longtime business relationship and shared technology with Catamaran greatly simplifies the integration now
underway. Our clients, partners and members can expect stability and a smooth transition.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the agreement, all of the shares of
Catamaran were acquired for $61.50 per share in cash, with all shares of Catamaran expected to be delisted from the NASDAQ effective as of close of trading today and from the Toronto Stock Exchange (TSX) shortly. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the completion of the acquisition, Catamaran repaid in full and terminated its existing credit facility. On July&nbsp;23, 2015, Catamaran
also delivered an irrevocable notice of redemption to holders of all of its outstanding 4.75% Senior Notes due 2021 (the &#147;Notes&#148;) and irrevocably deposited with the trustee sufficient funds to fund the redemption in full of the Notes on
August&nbsp;23, 2015. As a result, Catamaran and the guarantors under the Notes have been released from their respective obligations under the Notes and the Indenture (in each case, subject to certain limited exceptions), pursuant to the
satisfaction and discharge provisions thereunder, effective as of July&nbsp;23, 2015. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About OptumRx </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">OptumRx is an innovative pharmacy care services company managing the prescription drug benefits of commercial, Medicare, Medicaid and other government health
plans, as well as those of employers and unions through a national network of 67,000 community pharmacies and state-of-the-art home delivery pharmacies which have earned the prestigious Verified Internet Pharmacy Practice Sites&#153; (VIPPS)
accreditation by the National Association of Boards of Pharmacy. OptumRx is part of Optum, a leading information and technology-enabled health services business dedicated to making the health system work better for everyone. OptumRx and Optum are a
part of UnitedHealth Group Incorporated [NYSE: UNH] with principal executive offices located at UnitedHealth Group Center, 9900 Bren Road East, Minnetonka, Minnesota 55343. Visit <U>www.optum.com</U> for more information about OptumRx and Optum.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Contact: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Drew Krejci </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Optum </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel: (952)&nbsp;205-6652 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>andrew.krejci@optum.com</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g84129img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g84129img01.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`-@"R`P$1``(1`0,1`?_$`*$``0`"`P`#`0``````
M```````'"08("@($!0,!`0`!!`,!`0`````````````!`@,$"08'"`4*$```
M!@$#`P(#!08'```````!`@,$!08'`!$($A,)(10B%18Q02,D%S*V=Q@X"C-V
MAM:76#D1``(!`P($!0(%`P0#``````$"`P`1!`4&(3$2!T%1(A,(,A1A<4(C
M%8$S%I&Q4F)R)`G_V@`,`P$``A$#$0`_`._C2E-*56;:_)/0Z[GB6QK'006B
MBP"01TK<89Z<TBI9&KEPE-HP[!PBBQE(Z(Z")]15B]\Y5#)G$A2]6N[N5_\`
M0+:?;[ND=LP:<=4V!BM[&7G8\G[Z9`8AV@C<+%/#&0(SZTZVZG20KTAO1FW_
M`(]:OKFT5U>7(^UU^;UQ02+Z#$0"GN,"61W^KZ3TBP9;DVWPQYE7'V5HDLS0
MK1%V!N4B8O&K9P4LI%JJ$(<&TO%*B20C'``</A63+U`("41*("/MOMYW$VCW
M4VGC;VV/EC,V]E7Z).AT(939XW21597C;TNI'`C@2.-=&[@V]JVUM5DT77(C
M#J,5KK<-P/%6!4D%6'$'Q%2%KFU?%II2FE*:4II2FE*:4II2FE*:4II2FE*:
M4II2FE*:4II2FE*:4II2M0.8&>HO$M(3J3.:;Q=^R4REHNLG5*[$(V,;)MT;
M!8#J-$%C(GCFK\I&^XE,9RH4Q=P3/MXK^<G?\]D^T63@:'[C[ZUV*3%Q!'P:
M&)@$R,KJ-@IB1PD/J#>\Z.H(C>W<G9;83[QW.N;EIU:%I[+)+R];W)BBL3Q#
ME;OS'0I!XL*J#J?&AGDJ<@HZ)E_?3+YXE\O>PJ*#<R9B`*RJCAV=543MTD2F
M,H"@?L@/IOK\\G;>/?G<K?>#VSV7@&?7]5F,213,>@"Q:21S8!$CC5I'<'@J
MGF;"O<6X-S8.W=+FUG4Q[>)CKU,3>YXV"@#F6)``\S6:6WAEF_B;?QS=0<AS
M:_L'_N5+9$L6[B..V=G[9H>Y5GO)**0:PJ%1$BAEFVXD$IR*`40_6-L#:&C]
MO-CZ5L308EBTC2L"+'0#Q**.N1C8=3RR=<CL1=F8D\36LC7]6S=?UO*U[/8M
MF94[R,?+J/!0/`*ME4<@`!5L&#^3,1D>79X[N#9K5<M'K)+4$&@=4\+8H<JX
MMGK^KO'!SJK+1:PE!XR5$5VW6!@%5/=0.4CB+CE>OG`\;'ZJVGTJJFE*:4II
M2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4K\U54D$E%UU$T4$4SJK+*G
M*FDDDF43J***'$")IID`1$1$```W'5C*RL7!Q9,W-DCAPX8V>21V"(B("S.[
M,0JJJ@LS,0%`))`%5QQR2R+%$I:5B``!<DG@``.))/``<ZYL.8)LO97SY8\F
M,(I29JD(X2@Z,WBWR#E1M4H8ZA2'^6G5(Y(M-N%5W:P%*8=W'3]A0`/S6_)3
MY)[1[Y]V-5U.///\!%(V'@^XK(GVT+,L<B'BH$S]61<D&\EB!8`;&>U^VL?9
M>T,72Y`$U)Q[N0?$S.`2I/CT+TQC_P`?QO5@_CCQ<G\ML>8I!+XWJAJQ6$C*
M%$6Z:0)KSSM9L!A%!X*ITFP=8`<I2JA]AM>ZO_FAV1CQ<;4N]FO8ZMFNS8.F
MLP4E8[!LN=/$>Y>.)'%KH)0+AC72GR5W@[RXNS,1B(@HR)^!'43<0K?Q`'4Y
M\+])\*M&<-V[M!9J[01=-G"9T5V[A(BR"Z2A1*HDLBH4R:B9RCL)3`("&MM]
M>3JK%YT\4C3-#/E7%$D-,N&)SNK]'/FLB>*4B$H9L+V67B9`#%.S3.T:]TR7
M7T=Q$HE#81*.-E9N'I6++J&H2)#I\,;/*[FR(B`LSL3R55!)/E5_%P,S5<N+
M3M.B>;4)Y5CBC0=3N[D*J*!Q+,Q``\34N<0^7=4SC"1E2E++%O\`(C"*(H9T
MV<M.Q;6C9,`/*,TTE=R27:+W'*'0F/[1R%Z`,!+T,L.3`F5C.LF-(@9'4AE9
M6%U96%PRD$$$$@BK4L<V/.^+E(T>5$Y1T8%65E-F5E-BK`@@@BX-;R:KJFFE
M*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*U*YE9#M-&Q,NRIM"N=^
MF[<Z-"BRI\)(RPL(Q-(74DYE7,>V=!%M'"100[BA!`Q5#[`(AKQ3\\<SN%F=
MC\C8/;G3\_+U+<<OVF5-CX\L_P!K@*/<RBRPJQ#9`"XZANE#'),2P*@'M[LK
MIVBY&\4U/7<O&Q<3!7W4$TB)[DI/3&%ZR.KI-W-N(*KYUS19LS3D<6<Q]4)R
M%2:LDC&1JI6KV%,9938K-![[LB$@],H<Y=^OX!#<0(`:T4;;[38>V]5BTO+P
MYDU@D=;9,;+*HM=B(W`]OARL+\1Q-;"]M:?CZ_J$&+@R)+'*_%U8.`HXN;J2
M.`!_K4,\5>2&6<,3,C)8ZN<C`2Q%E7SEJ82OX.9;/U>IVC+03[O1K\".?4IS
M)]U/KW(<H@`Z]O\`;GN#NWMYF#+VCF28DB*`4X/"Z<NF2%KH]K"Q(ZA^D@UW
M3OSMMLS?FE)I&Z,&+)PD4!&^B6+I%@8YELZ<.8!Z3^I2*Z3^+WD%A<IQ==B<
MO1+&AVR6ZFZ$\R<"%,E%2'[+=9<SY7W5=5?G(.Q%3K-P';\8-P`/9G:_Y];`
MU_>"=M^XR#1]Q=:Q+F]2C3I9F52%=W;JQ6)/3>0M%U\#*MP*UM]V_C+J.T<C
M)U#9,TFHZ-#ZC"P_]J,<R`$'3.$'BH5R/T&UZSWR&VQY%\<IFJPT@W9R.3GC
M>HE<'(*Y?DJS=>1FCI=I4A@!=HT*AW`Z@*#C?8?L'F7SC[Q1=JNS2"!%GFU[
M/CPND-9OMFC>;(DC/(D(BH+^F\HN?/CGQAT*'4.Z,&KYT;/C:1&<FPX?NA@D
M0-P>3,7MPOT<QSKG3XAT^PPO.'`U/<I.$(Z3R,VF&_9%5,S4D$W=V&201=)@
M0#L'*+(PE]1*)#@`;#N`]'_$'Y`:O-JNG]OX'&I;+U(N,:Y`EP9.EI&`/$^W
MP8/`WTGU1D6(;U'\H>SVS]S;2S.[ND.N'N;"1'R"H]&8A9(@LB`^C(4LMI1Q
M8`B0-P9>QC6T"M:-1[?,MXJQ8BU<9-R70<>(/A,#%6[W"OU4KT2=74#,9R08
M^Z$O2.X)]0^FI"D\@34$@<Z^9C[.F%<LCTXPRWC;(*H)=X[:FW:N6-XBETB8
M3KLHJ1=.VX`4-QZR%V#0JPY@B@(/(U(4U-PU;B9&?L4O&0,%#LUY"6FII^UB
MXF+8-B"JY>R,B^509LFC=,HF.HH<I"%#<1`-1SX"IJ&PY2\9!$`#D7@H1$=@
M#]7*!ZB/^H-5=#^1_P!*IZE\Q4L5NUU>Y1B<U4+)`6J'5,)$I:MS$=.1BA@*
M4XE3?QCATU.8"'`=@.(["`_?JD@CG55[\JBYWR;XW,';M@^Y!819/F#IPR?,
MG>5J(W=LWK18[=VT=-UIXBS=RV<)F(HF<`.0Y1`0`0$-5=#>1JGJ7S%>O_--
MQD_[%X)_Y<H'^X-.A_(_Z4ZE\Q64/<WX7C:K%7J1R[C!A2)UVNP@[B]OU5:U
M:9?-3.B.6458%Y8D3(NVYV2P*)HK'.043@(!T&VCI:]K&]3U"U[BU2*P?L91
MDSDXQXUD8Z0:H/6$@Q<).V3YFZ2*NV=M'3<ZB#ELX1.4Z:A#&*<H@("(#J*F
ML,L>5L74^PQ-2MN2*%5[5/@T-!5FQ7"O0E@FBOWIXUB:)AI*1;2,B5[()F01
M%%,_<6*)"[F`0U(!(N!PJ+@<#SI8,K8NJ=CBJ=:<D4*M6Z=!F:#JT_<*]#6.
M9+(.U&#`T5"2,BVDY`'S]$Z"(HI'[JQ1(7<P"&@4D7`-J7%[>-9]J*FHZM^7
M\2X^E&$'?<H8[I$U*-TW<9$6ZZUJMRDBU5<G9).6+"9DV3IVW4>)F2*=,ABB
MJ42@/4`AJ0K'B`;5!(',U[L]DW'%6ETX"S7ZFUV<69&DDH><LT-%2:D<0CA0
M[\C%\\0<F9D3:*F,J!>@"I'$1V*.P*Q%P#:EQR\:R9E,Q$DNZ:QTK&OW3%-D
ML];,GS5TNS1DT!=1RKI%!511NG(-@[B!C@`*I_$7</745-?2TI32E1]D/$^,
MLM0KFNY,H54O,,[1[*K.RPC"4`A-Q,4S9=RB=RR63,(B11$Z:A#>I3`.N.;A
MV?M7=F.<;<NG8>=$5M^]$CL!_P!6(ZD/XJ01X&OO[>W5N3:><FI;:SLK!SD-
MP\,C(?R(!LP/B&!!'`@U3EG_`,--+]TC=.*\VXIL\BZ-\SQ[<)=W)U"4BG'>
M%VC!3"R#N;A9%,1(")'*KEJ;I]12VW'QWW*^&VCY$3:KVLE.)J@))Q<F1F@<
M68],<I#21M>P'672WBMN/LSMM\T-;Q7&F=T8%S-/*^G*QXU3(1A8`RQ@K'(A
MXDE%1P?!K\*FL[Y#S!@&>/CRQX:E<=RD64C)JXNJ9GK*2:()BFB\@W,2H$)*
MM5B)]15$';@@AOOL(#K4KN;XV;HVGN#(C[GC*@U:25G943I1BS%B4F/4LJ<>
M#1\/"_"U>R=E_P")[^P!N#1=5AS\60EC[!LR$FY617_<C8$V(=%/EPJ//YH\
M^6*CQGU';7LS5*Q+OQBZ^BW;$1@VCQNU)(/(D5R+K)E!5`@&3,<4P`!$H%$3
M"/-9=#@U/;&#MK79<W4=N:9+*V+CY.3-*F.9@@E,0+`(K>VGH'H6Q*A2SD\C
MQ.W>R]-U6?4<#"BCU3*1!+*+AI>@L5#VL"1U'C:YX7)L+6"^,":4RCRLJ4HZ
MD?J!O4*I=+$D#D&P.(ATO$_($UCH=D'"(B:9$GH(%ZA*.X_#OZ>^&FR=LX?>
M?'S]$PXX3CX.3(Q1G'Z/:4LI8@V,G`D<"00?/H/Y7KBZ#V;RX,9!#)F9N+#P
MOZP)/=(O>W*/\>%QYU=SSIY(AQ0XN93S.U3;N+)"Q",-1F;H"G;NKS9W:,%6
M!<(G*8KEG'2#T'CA+T[C9LH7<-]PW`QKUN%K5$[=*DU1+P&\8Z_-6OR7+/G%
M:+U=RY)<J2%"CQMCMK,6*/.Z<FD;--O4TS.H>%6D`%*-C69VZ0))F/T%1%(I
M\B27H/1'X592/J'4]9ISI\0].X]8UF.3G#"?R#2+MA],MSE:\2U/'C@E=A^\
M\FY^HSO;3L$?-038A70MSN5&ZS9%4H%`_24T1S%CT/:QJ7B`'4O,5-F.>7L_
MS"\0'*FQW]TT?9/H&*\IT.^/&K1)FC,JH50\I`V`6:(F005EH.02!<"])3.4
M53E(4IBEU2R!)A;D34JW5&;\[5K3XQO&+Q/Y5\3(;*^6JU9W5U?W*_5Y>0@;
M4\A6_L8*948QIR,4T5VH.4$-MS"40.(`)@'5<LKH]ARJF.-66YYU$BE%E_&'
MY2,0X?P#DJU2.,,HRF+_`*GI\G(MI-T]K5[L3RNR5;M#!DUCXM_,-%&!GD6\
M!NBZ("B?Q=(FZYO[L19AZJBWMR`#E5C7)[P_\,(3&V?<TM("]FNK6M9*R8FH
MM=%CQHV=5K,6<ZAV)6!-V0RJHCVNL/P_AW^_5I)I+A;\*K>-0"WC5>_B?\<G
M&3F%@>WW[,L+:'5D@LBOJTS<5VRJP;8T6E$1;Y(B[4C5RF=8BSH_QAT[E$-]
M]79I71K*>%JHCC5AQJ8?,Y@/'G&O@[QEPOC)G(-Z/4,T64\,WFGWS>03-.UZ
MYV!^*[XZ*(K=4C**B7X0Z2"!?NU3`Q:0L>=JF4!5`'*N@'C.`!QUP4`>@!B+
M'@``?8`?2D5K'?ZS^=7D^@?E7/5Y9DTS>5'@X8Q"&,6.P9TF,4HF#;D)8A#8
M1#<-AUDP_P!IOZ_[5:E^L5%?G#I=IR!SSPY4Z)%/YJZR^!*ZE6(R'*J:;?RS
M6\Y(>M6D-[?9T,JH=O\`E@3$%!6Z0*(&VU,!M&2>5ZIF^L6YVJQK@AY/:3(<
M)KG;>0=E4;Y-XLPH0F06<@=-"S79FBHI&T1[&LUS%<2%AL3E).(<@)>L)5,R
MBW054!U:DB/7Z>1JXD@Z+GF*YFLX9"S1G[,%6Y)YJ;R"JF7;V4E+=/FX(1;>
MO5*SPZ!*W54#%*!8"J$FD6Q%"%Z5EA.H8QU3*FUEJ%5>E?"L=KD]1\:[T<CX
MH@\EF9&F'CYI[*O7NN%*S39'*LSOU<4K4DHJ#MJXW59M%141`-B=S]L#%]-?
M.!MRK,(O7Q,/8`Q[@M6T%QVS>Q4;:A@E'D4YD7LHW:KP39ZS;G9.9-=Y()H&
M:.B(D;BL+=J@W220(DF0"ZEF+<^=``.53;JFIII2FE*:4J*LRX3QCG^C26.\
ML51A:ZO)`!_;N15;O8YXGZMY.&E&IT7\3)M3@`D604(;;<INH@F*/%]X;+VU
MOS1)-O[JQ4RM,D\#<,C>#QNI#1N/!E(/@;@D'E6SMZ[FV#KD>XMJ94F)J<?B
M+%74\TD1@4D1O%6!'B+$`BAGD/XHK=B.#?2N"W<ED^@M&SYP_K$D"!\@QC54
M5%7/MR,D&S2UH`100`&Z2+L```[2FPGUKU[H_$G7MJ02:ML%Y-4T)%9F@8#[
MN,<STA0%G7R"*L@_X-SK8AVJ^76W]US1Z1W`2/2M>=@JSI?[.0\AU%B6QV_%
MV:/_`+KP6L;\)6/5HGD3G^5>(J)K4['D56TRN$5$'*(V>SIO2E5*J4IR'%&L
M&*H00`2G)ZA]FLGX2:*R;XUS/E4B7%T]82#P93-,K6(/$']DW!\>?*L;YP:R
MIV'H6GQ,&CR]1>:X(*L(8"H((X$?O@@C@0>%61^8/$D[EW@?E5G6VSE]+4-Y
M6\H$C6B9UG$A'4R3*YL"**293J*J-Z\Y=N"E*`F,9$`#U'6RZ!NF07\:UE2B
MZ&H[\._+K'N:N,E*PZ$FQB<J85@VU3EZR\?L$I"PP+0#*1-P@&!52.740LW6
M!!QTD$6[E(>O8JB8C,R%7)\#41,"MO$5-GDTY48]XZ\5\N,I>>@W&0\@4F<Q
M_1:,:2:&GY:2O$:]KPRPPY5PD"P4"R=+O'3D2`B!6_;ZNXH0HQ$A9QY55(P5
M3YU4/P?Q+8J#X:N;MVGF[ADURU4\G3M;:ND%$55:_7*"A6494O<(3K0DG[)P
M"8AN`E2W`?7TO2$&90/"K:"T1/YU'/CPPEY,,@\8XF5XN\FZ=BC#KVUW:.;U
MB6CHQ6:8S"4L=O8Y%%XK19UZ3WCL152$KPIB#ZE`GII*T0;UBYJ$#E?2;"K)
M^)OB<GJ!G)'E'RRS:_S[G*-E&TW!NF:TNG$LYJ/;>PC9F5EI;V\K.*1S`A$V
MK3L-6C;ME`"G*4"ZMO-=>A!9:K6.QZF-S5DO+;^EWD-_!K(W[JRFK2?6/SJM
M_H/Y55%_;]?TJ9)_C)(_NY!ZO9'U#\JMP_37G_<"521E^*.-+.T3448U+-D4
M67%-%10K9M8ZI9XAJ\74(`D00+)"BCN;8#*+E*`[B`"QSZR/PI,/3?\`&K%^
M`F9*;FCB1@RRU:8C':\=C>KUVSQ35\W7>UNR5N*;PLU$2K8BIG#)9N^8'$@*
ME(*B)B*`'2<-6Y%*N;^=5H04%JHIYXV>$Y!^8WB]1,=OFL^XQM*8<J=CD8AV
MC)L6TU#9!F<BV!J==J*B)#UV(>ID>E`QC(*E.0P`H0Q0OQCIA)/C>K3GJE`%
M3GS?_P#;#@G_`)5QW^_^2M0G]AJ2?W5_I6-\W/#[8,J<U*9<<2)JPV(<]V![
M,YJ?MB*K)8UGHX!EK5,MDQ`Z?8O30ASL$SF*DG,F.3X$U$@!',!'8_4.52\5
MWN.1J'/-O1:QC'(?`S'E*BT(6ITNG2M<K\6W*4J;2-B[E0&C<IA*4O=<*%3Z
MU5!#J55,8YMS&$=50$D,3SO5,W`@#RKJSUAUDTTI32E-*4TI32E-*4TI4=5S
M]*_KBZ?2?T5^H79BOU`^0?*/J7HZG?RCZJ]A^=[N_>[/NOCVWV]-<;TS_$_Y
MS._A_L?\AM']W[/M^]^KV_?Z/5?ZNGKX\ZY+J?\`EO\`!8/\S]]_CMY/L_>]
MSV?T^Y]OU^FWT]71PO\`C6?.O;>V<>]['L^PM[OW7;]M[;MF[_N.[^%V.UOU
M]7P].^_IKDE<:KDVY08D\/=^R/(O<'\KY?`>1D)N7+,16-\49NR72Y&7[YRN
M3U0M:JAV\<F1UW3G&&?KLE2])42)$`1-F(TP'J%Q^8K'(B)X&QK'L&88\1M*
MR4RE.1_,>VYLN9'R(J5R^X;SUCB"/(=P"A]9NK/4'$@XBQ/U&.1\\:I%/_B*
M&(`E$S3$>A;+_2H`C!]1N:Z2.3T-BFQ<.\R04Y<H['>&9;"MC8/;U5((;-%5
M.B.:ZHF$]7Z]6TE_G+"-BC`HW;,B&!5,I2I@("&L9;]8_P"5ZR&MTF_*U0CX
MLZ=A>B<2H.OX#S$_SICM*\WYTUR!)4>;QZZ=2KN;,K+Q9JW8&K.21)$NOPBK
M"0"+!\11$-3*6+^H6-4QV"^GB*L7U;JNH>Y"1U;E\%9ABKC8E:C4Y'&UR962
MTH1CJ:6KL(Y@'R4G-)1#(BKR34C6ASJ@@D4RBHEZ2@(CJI?J%N=ZAK=)ORK0
M/Q$T'CYCW`=UB>.>>I/D'47.2'CV4MDICFQ8T7C9LT-%I*0Q(:RLV3QTFFU3
M34[Y"B014Z=]P'5R8L6'4+&U41A0/2;U8-G+](AQ'D`,]#6@Q`-9D_KX;;T_
M(PK_`+<_NQ<;@*_N`#;V_M_S7N.CL?C=&K2WN.GZJK-K<>5<B-LX[^-&:LU@
ME>/'D,R=1*B]3.K)U/\`ENY&W5>&A!1)[IL^L4#5:\Z?Q?<[HE&00$"(B4IS
MJ"!E#9O5+;U*+_F*QB([^D_[U;MXK*9XT://R41QOS$WS;G\(EV:<N%OJ-TH
M]C5C`6`'Y*G7KK!0[5DB(C^9!DHZ<B`*"8X)B<H69C*?K%EJ[&(Q])N:SWE#
MCCC1.^3CBI=[YR-E:-G6!@:<EC_"3;%]GL$??&C:VW9Q&NW-^CV*T!732,BZ
M=-Q(X5(*0-@.;8%"B,(7$1`%U\[T<+[@)/JJY+5BKM46^6O%G%#(&6.-TAR(
MY23.`+#"L9PM)@(S$5NR2E<TE;75'#M5Q)5R/>MH(6L@W;MP!<2"<%Q.'H0=
89$)<*>D7%69`A(ZC:KTM8]7J:4II2O_9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
